Rheolytic Thrombectomy For Acute Deep Vein Thrombosis Of Whole Lower Limb
ConditionDeep Vein Thrombosis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorRenJi Hospital
About this trial
Ipsilateral popliteal venous the most common access for pharmacomechanical thrombectomy (PMT) in the treatment of acute deep venous thrombosis (DVT), but the result was not satisfactory. The investigators adjust the access to improve the thrombus clearance rate and reduce the incidence of post-thrombotic syndrome (PTS).
Eligibility criteria
Qualifiers
Age between 18-80 years old;
Acute DVT with clinical symptoms occurred less than 14 days since the onset of disease;
DVT with thrombosis involving the iliac vein, common femoral vein, distal popliteal vein, and/or calf vein;
Informed consent signed by patients.
Disqualifiers
Patients with the previous history of the same side of lower-limb DVT;
Patients with plasma Creatinine level greater than 180umol/L;
Patients who are contraindicated to thrombolysis;
Patients with inferior vena cava thrombosis;
Trial design
Treatments tested in this trial
- pharmacomechanical thrombectomy (PMT)
Treatment groups
160 Participants
are divided into 2 treatment groupsSponsors and collaborators
RenJi Hospital
Lead sponsor
First People's Hospital of Hangzhou
Collaborator
The First Affiliated Hospital with Nanjing Medical University
Collaborator
Affiliated Hospital of Nantong University
Collaborator
Chengdu University of Traditional Chinese Medicine
Collaborator
Second Affiliated Hospital of Suzhou University
Collaborator
Liuzhou Workers' Hospital
Collaborator
Shanghai Pudong New Area People's Hospital
Collaborator
Zhejiang University
Collaborator
Source ClinicalTrials.gov